On the recordSeptember 25, 2007
There is a regulatory black hole that makes it possible for the pharmaceutical companies to be able to get the drugs to the stores that sell them, without the FDA being able to monitor it.
Source
transcripts.cnn.comEd Markey: “There is a regulatory black hole that makes it possible for the pharmaceutical companies to be able to get the drugs to…”
Editor's note · Context
Rep. Edward Markey discusses the lack of FDA oversight allowing unapproved drugs to be sold.
Share
More from Ed Markey
Aug 12, 2026
Over the past two years, my office has been working closely with the family of Robert Gilman – a Massachusetts resident and former Marine who has been wrongfully detained in Russia on questionable charges for 1,666 days.
Aug 12, 2026
As with other efforts to erode federal civil rights oversight and enforcement, ED’s proposed rule is ‘like throwing away your umbrella in a rainstorm because you are not getting wet.’
Aug 9, 2026
Voting for this Continuing Resolution would be signing a check for President Trump to continue his illegal, reckless agenda, including ICE raids, an unwinnable war in Iran, threats to interfere in our elections this fall, and the…
Aug 11, 2026
The FDA is correct in its recognition that the GRAS rule is flawed and overdue for correction, but this proposed rule will not protect families from exposure to dangerous food chemicals.
Other voices in this conversation
